By JESSICA ROSE
“The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.”
Head to the FDA website here.
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
So listen. The bivalent shots âprovideâ, at best, an immune tickle against two extinct SPIKE variations. Furthermore, recently, bivalent vials have been sequenced and found to be contaminated. Adverse event reports have been piling up in VAERS one week following original release-for-administration date, on September 2, 2022.